-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Performance-driven and mission-focused—Keway Pharmaceutical Holds 2025 Sales Target Achievement and First-Quarter Winning Start Meeting!
Publish Time:
2025-01-24
Over the past year, all employees at the Keyuan Pharmaceutical Marketing Center have worked together as one, proactively tackling market challenges by strengthening marketing efforts, optimizing sales channels, and enhancing customer service quality. Looking ahead to our 2025 goals, everyone in the Marketing Center is determined to shift our work style—approaching the market with respect and deepening our understanding of both market dynamics and product trends. We’ll gain a clearer grasp of customer needs and market shifts, enabling us to develop precise marketing strategies, expand our distribution channels, and wholeheartedly deliver a strong start to the first quarter.
Pursue truth and pragmatism, relentlessly focus on performance, and courageously move forward to ensure mission success! On January 22, Keyuan Pharmaceutical (stock code: 301281.SZ) successfully held its Marketing Center’s 2024 Annual Summary Meeting, along with the 2025 Sales Target Achievement and First-Quarter "Opening Red" Kickoff Conference. The event comprehensively reviewed the marketing achievements of 2024, outlined and implemented the 2025 sales targets, and inspired all employees to work diligently toward securing a strong start in the first quarter.
Over the past year, all employees at the Keyuan Pharmaceutical Marketing Center have worked together as one, proactively tackling market challenges by strengthening marketing efforts, optimizing sales channels, and enhancing customer service quality. Looking ahead to 2025, the entire marketing team is determined to shift our work style—approaching the market with respect and deepening our understanding of both market dynamics and customer needs. We’ll develop precise marketing strategies, expand our distribution channels, and give our all to ensure a strong start in the first quarter, delivering outstanding results right from the beginning.
At the meeting, marketing professionals from various company regions engaged in in-depth discussions and analyses, sharing insights on their respective target strategies, the current market dynamics, competitive landscape, and evolving customer needs. Together, they explored future marketing approaches and market expansion directions, while also exchanging successful experiences and innovative tactics—providing valuable ideas and guidance to help achieve business objectives.
The meeting emphasized that, in 2025, Keyuan Pharmaceutical should strengthen the implementation and construction of new production lines and projects, encourage innovative business models, and make every effort to ensure efficient execution. At the same time, the company should accelerate its internationalization strategy and continuously expand its market share in overseas regions. Additionally, all employees were urged to adopt a more proactive work style, focusing on solid, results-oriented tasks, timely feedback, and cultivating problem-solving mindset—ultimately injecting fresh momentum into the company’s steady growth and development.
Though mountains and seas may lie far apart, our mission ensures we fulfill our original aspirations; embracing responsibility with courage, we move forward boldly, shining with unwavering dedication. The convening of this meeting serves as a powerful boost, propelling us toward a strong start in the first quarter and helping us achieve our 2025 goals. All members of Keway Pharmaceutical are determined to unite as one, giving their all to deliver even more outstanding results in 2025—and to write an even brighter chapter ahead!
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline